CompletedNot Applicable

Mobile App-Supported HPV and Breast Cancer Awareness Program

Turkey (Türkiye)70 participantsStarted 2025-11-02

Plain-language summary

The goal of this study is to learn about the impact of a mobile application-supported education program on women's HPV literacy and their beliefs regarding breast cancer screening. The main questions it aims to answer are: * Does a mobile application-supported program increase HPV literacy levels among women? * Does this intervention strengthen women's positive beliefs and attitudes toward breast cancer screening? Researchers will examine how this holistic, health-based intervention changes participants' awareness and screening perspectives. Participants will: * Use a mobile application designed to provide education on HPV and breast cancer * Complete surveys regarding their HPV knowledge and breast cancer screening beliefs before and after the program * Engage with health-related content through the mobile platform for the duration of the study.

Who can participate

Age range

30 Months – 65 Months

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * -Women aged 30-65 years * -Literate (able to read and write) * -Able to understand and speak Turkish * -Able to use a smartphone * -Willing to use the mobile application during the study period and consent to data sharing Exclusion Criteria: * Having undergone regular breast cancer (mammography) and/or cervical cancer (Pap smear/HPV DNA test) screening within the last 3 years, in accordance with national screening guidelines * Previous diagnosis of any cancer * Neurological conditions affecting cognitive function (e.g., dementia, Alzheimer's disease) or physical/psychiatric conditions that would seriously limit study participation and mobile app use * Pregnancy or breastfeeding * Participation in another health-related research study during the study period

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in HPV literacy (HPV-LS total score) from baseline (pretest) to post-intervention (posttest) compared between the Mobile Application-Supported Education Group and the Control Group.

Timeframe: 12 MONTH

Change in breast cancer screening beliefs (Breast Cancer Screening Beliefs Scale total score and/or subscale scores) from baseline to post-intervention compared between groups.

Timeframe: 12 MONTH

Trial details

NCT IDNCT07471113

SponsorAtaturk University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-25

View on ClinicalTrials.gov More Human Papilloma Virus trials

Plain-language summary

Who can participate

Age range

30 Months – 65 Months

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in HPV literacy (HPV-LS total score) from baseline (pretest) to post-intervention (posttest) compared between the Mobile Application-Supported Education Group and the Control Group.

Timeframe: 12 MONTH

Change in breast cancer screening beliefs (Breast Cancer Screening Beliefs Scale total score and/or subscale scores) from baseline to post-intervention compared between groups.

Timeframe: 12 MONTH